Wall Street Analysts Think Rhythm Pharmaceuticals (RYTM) Could Surge 26.36%: Read This Before Placing a Bet

Group 1 - Rhythm Pharmaceuticals, Inc. (RYTM) shares have increased by 0.3% over the past four weeks, closing at $56.52, with a mean price target of$71.42 indicating a potential upside of 26.4% [1] - The mean estimate consists of 12 short-term price targets with a standard deviation of $6.87, where the lowest estimate is$60 (6.2% increase) and the highest is $80 (41.5% increase) [2] - Analysts show a strong consensus that RYTM will report better earnings than previously estimated, which is a positive indicator for potential stock upside [4][9] Group 2 - The Zacks Consensus Estimate for the current year has risen by 2.3% over the past month, with one estimate increasing and no negative revisions [10] - RYTM holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, suggesting a strong potential upside [11] - While consensus price targets may not be reliable for predicting exact gains, they can provide a directional guide for price movement [12]